https://www.pharmaceutical-technology.com/data-insights/dn-1508052-shanghai-de-novo-pharmatech-colorectal-cancer-likelihood-of-approval/
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Colorectal Cancer.
de novocolorectal cancerdnshanghaipharmatech
https://www.pharmaceutical-technology.com/data-insights/sumecigrel-jiangsu-vcare-pharmatech-ischemic-stroke-likelihood-of-approval/
Sumecigrel is under clinical development by Jiangsu Vcare PharmaTech and currently in Pre-Registration for Ischemic Stroke.
ischemic strokejiangsuvcarepharmatechlikelihood
https://www.pharmaceutical-technology.com/data-insights/dn-1508052-shanghai-de-novo-pharmatech-hepatocellular-carcinoma-likelihood-of-approval/
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Hepatocellular Carcinoma.
de novohepatocellular carcinomadnshanghaipharmatech
https://www.prnewswire.com/news-releases/wuxi-pharmatech-provides-update-of-2010-financial-guidance-to-present-at-jp-morgan-healthcare-conference-113194479.html
/PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company,...
wuxi pharmatechfinancial guidanceprovidesupdatepresent
https://anyflip.com/metpt/qixq/basic
View flipping ebook version of PharmaTech_May-June 2024 published by PharmaTech - Bimonthly Magazine on 2024-06-12. Interested in flipbooks about...
pharmatechmayjuneflipebook
https://www.pharma-tech.in/
PharmaTech Summit 2026 - Empowering Pharmaceutical Innovation through Digital Transformation
tech summitpharmaawards
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-nationwide-recall-all-liquid-products-manufactured-pharmatech-llc-and-distributed-leader
As a precautionary measure, the distribution firms Leader Brand, Major Pharmaceuticals, and Rugby Laboratories are jointly issuing a nationwide voluntary...
liquid productsvoluntarynationwiderecallmanufactured
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-cf-pharmatech-aurealis-pharma-atyr-pharma-5913385/
CF PharmaTech has secured $65m in a series D financing round led by SDIC. The Chinese respiratory drug developer plans to use the funds for the development of...
dealsweekcfpharmatechaurealis
https://informaconnect.com/lsx-world-congress/speakers/?searchInput=&stream=1&stream=2&stream=14&stream=4&stream=0
Meet LSX Europe 2026's expert speakers: leading Biotech, Medtech, & Pharmatech CEOs, pharma executives, top investors & healthcare innovators sharing insights...
world congressspeakerslsxeuropebiotech
https://www.choosedelaware.com/press-releases/wilmington-pharmatech-to-expand-in-delaware-planning-new-large-scale-manufacturing-facility/
Oct 16, 2025 - PharmaTech is planning to hire up to 139 new employees and invest $18 million in a new science research and manufacturing facility in Newark.
wilmingtonpharmatechexpanddelaware